|
LifeMD, Inc. (LFMD) DCF Valuation
US | Healthcare | Medical - Pharmaceuticals | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
LifeMD, Inc. (LFMD) Bundle
Discover the true potential of LifeMD, Inc. (LFMD) with our advanced DCF Calculator! Adjust key assumptions, explore various scenarios, and evaluate how changes affect LifeMD, Inc. (LFMD) valuation – all within one comprehensive Excel template.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 12.5 | 37.3 | 92.9 | 119.0 | 152.5 | 250.3 | 410.7 | 673.9 | 1,105.7 | 1,814.2 |
Revenue Growth, % | 0 | 199.1 | 149.04 | 28.16 | 28.15 | 64.08 | 64.08 | 64.08 | 64.08 | 64.08 |
EBITDA | -2.6 | -57.5 | -53.9 | -39.6 | -8.2 | -108.7 | -178.4 | -292.8 | -480.4 | -788.2 |
EBITDA, % | -20.48 | -154.14 | -58.08 | -33.28 | -5.38 | -43.45 | -43.45 | -43.45 | -43.45 | -43.45 |
Depreciation | .3 | .4 | .9 | 3.8 | 6.6 | 6.1 | 10.0 | 16.4 | 27.0 | 44.2 |
Depreciation, % | 2.69 | 1.07 | 0.9354 | 3.17 | 4.33 | 2.44 | 2.44 | 2.44 | 2.44 | 2.44 |
EBIT | -2.9 | -57.9 | -54.8 | -43.4 | -14.8 | -114.3 | -187.6 | -307.8 | -505.0 | -828.5 |
EBIT, % | -23.18 | -155.2 | -59.02 | -36.45 | -9.71 | -45.67 | -45.67 | -45.67 | -45.67 | -45.67 |
Total Cash | 1.1 | 9.2 | 41.3 | 4.0 | 33.1 | 51.6 | 84.6 | 138.9 | 227.9 | 373.9 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | .1 | 1.0 | 1.0 | 2.8 | 5.3 | 5.2 | 8.5 | 14.0 | 22.9 | 37.6 |
Account Receivables, % | 0.78155 | 2.68 | 1.06 | 2.38 | 3.46 | 2.07 | 2.07 | 2.07 | 2.07 | 2.07 |
Inventories | 1.0 | 1.3 | 1.6 | 3.7 | 2.8 | 8.8 | 14.5 | 23.8 | 39.1 | 64.1 |
Inventories, % | 7.62 | 3.39 | 1.74 | 3.11 | 1.81 | 3.53 | 3.53 | 3.53 | 3.53 | 3.53 |
Accounts Payable | 3.1 | 10.4 | 9.1 | 10.1 | 11.1 | 39.0 | 64.0 | 105.0 | 172.2 | 282.6 |
Accounts Payable, % | 24.47 | 27.91 | 9.75 | 8.49 | 7.27 | 15.58 | 15.58 | 15.58 | 15.58 | 15.58 |
Capital Expenditure | .0 | -.4 | -3.4 | -12.9 | -8.7 | -10.7 | -17.5 | -28.7 | -47.1 | -77.2 |
Capital Expenditure, % | 0 | -1.07 | -3.66 | -10.83 | -5.72 | -4.26 | -4.26 | -4.26 | -4.26 | -4.26 |
Tax Rate, % | -18.29 | -18.29 | -18.29 | -18.29 | -18.29 | -18.29 | -18.29 | -18.29 | -18.29 | -18.29 |
EBITAT | -2.8 | -58.0 | -54.8 | -43.7 | -17.5 | -113.5 | -186.3 | -305.7 | -501.6 | -823.0 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -.5 | -51.9 | -59.0 | -55.8 | -20.2 | -96.2 | -177.8 | -291.7 | -478.6 | -785.3 |
WACC, % | 10.55 | 10.6 | 10.6 | 10.6 | 10.6 | 10.59 | 10.59 | 10.59 | 10.59 | 10.59 |
PV UFCF | ||||||||||
SUM PV UFCF | -1,242.8 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -801 | |||||||||
Terminal Value | -9,326 | |||||||||
Present Terminal Value | -5,638 | |||||||||
Enterprise Value | -6,881 | |||||||||
Net Debt | -14 | |||||||||
Equity Value | -6,866 | |||||||||
Diluted Shares Outstanding, MM | 34 | |||||||||
Equity Value Per Share | -202.52 |
What You Will Get
- Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: LifeMD, Inc.'s (LFMD) financial data pre-loaded to kickstart your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
- Customizable and Professional: A refined Excel model that adjusts to your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- Comprehensive LFMD Data: Pre-filled with LifeMD’s historical performance metrics and future growth estimates.
- Fully Customizable Parameters: Modify revenue projections, profit margins, discount rates, tax assumptions, and capital investments.
- Dynamic Valuation Framework: Instantaneous updates to Net Present Value (NPV) and intrinsic value reflecting your adjustments.
- Scenario Analysis: Develop various forecasting scenarios to explore different valuation possibilities.
- User-Friendly Interface: Intuitive, organized, and crafted for both industry experts and newcomers.
How It Works
- Step 1: Download the prebuilt Excel template featuring LifeMD, Inc. (LFMD) data.
- Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly observe recalculated results, including LifeMD, Inc.'s (LFMD) intrinsic value.
- Step 5: Make well-informed investment choices or create reports based on the outputs.
Why Choose LifeMD, Inc. (LFMD) Calculator?
- All-in-One Solution: Combines DCF, WACC, and financial ratio assessments in a single platform.
- Flexible Parameters: Modify the highlighted cells to explore different financial scenarios.
- In-Depth Analysis: Automatically computes LifeMD's intrinsic value and Net Present Value.
- Ready-to-Use Data: Historical and projected data provide reliable benchmarks for analysis.
- Expert-Level Tool: Perfect for financial analysts, investors, and business advisors.
Who Should Use This Product?
- Individual Investors: Gain insights for making informed decisions about buying or selling LifeMD stock (LFMD).
- Financial Analysts: Enhance valuation processes with comprehensive financial models tailored for LifeMD.
- Consultants: Provide clients with accurate and timely valuation insights regarding LifeMD's market position.
- Business Owners: Learn how companies like LifeMD are valued to inform your own business strategies.
- Finance Students: Explore valuation methodologies using real-life data and examples related to LifeMD.
What the Template Contains
- Pre-Filled DCF Model: LifeMD, Inc.’s (LFMD) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate LifeMD, Inc.’s (LFMD) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.